HHC
PRAH

Hutchin Hill Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Hutchin Hill Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-227,600
Closed -$17.3M – 786
2017
Q3 		$17.3M Buy
+227,600
New +$17.2M 0.66% 30
2017
Q2 		– Sell
-291,760
Closed -$19M – 1113
2017
Q1 		$19M Sell
291,760
-505
-0.2% -$29.7K 0.52% 41
2016
Q4 		$16.1M Buy
292,265
+257,265
+735% +$14.1M 0.56% 32
2016
Q3 		$1.98M Buy
+35,000
New +$1.72M 0.04% 216
2016
Q2 		– Sell
-61,200
Closed -$2.62M – 777
2016
Q1 		$2.62M Buy
+61,200
New +$2.59M 0.08% 277

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hutchin Hill Capital's PRAH Position: Q4 2017 in Review

Hutchin Hill Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 227,600 shares — an estimated $17.3M sold.

Hutchin Hill Capital first reported a position in PRAH in Q1 2016 and held it in 5 quarters. The position peaked at $19M in Q1 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Hutchin Hill Capital reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 227,600 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $17.3M.
  • Hutchin Hill Capital first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 5 quarters.
  • Hutchin Hill Capital's PRA Health Sciences, Inc. position peaked at $19M in Q1 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.